[
    [
        {
            "time": "",
            "original_text": "十年磨一剑，哪些股票穿越牛熊？",
            "features": {
                "keywords": [
                    "长期投资",
                    "牛熊市",
                    "股票"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "十年磨一剑，哪些股票穿越牛熊？",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 4,
                "Duration": 7,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "2018中国上市公司最佳CEO榜单公布 9家药企高管榜上有名",
            "features": {
                "keywords": [
                    "CEO",
                    "榜单",
                    "药企",
                    "高管"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "2018中国上市公司最佳CEO榜单公布 9家药企高管榜上有名",
                "Correlation": 4,
                "Sentiment": 7,
                "Importance": 5,
                "Impact": 3,
                "Duration": 4,
                "Entity_Density": 5,
                "Market_Scope": 6,
                "Time_Proximity": 3,
                "Headline_Structure": 6,
                "Source_Recency": 2
            }
        },
        {
            "time": "",
            "original_text": "[增持评级] 昭衍新药(603127)简评：业绩维持高速增长 订单及产能带动增量",
            "features": {
                "keywords": [
                    "昭衍新药",
                    "增持评级",
                    "业绩增长",
                    "订单",
                    "产能"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[增持评级] 昭衍新药(603127)简评：业绩维持高速增长 订单及产能带动增量",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "前7月偏股型基金业绩排名出炉 医药基金继续领跑",
            "features": {
                "keywords": [
                    "偏股型基金",
                    "业绩排名",
                    "医药基金"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "前7月偏股型基金业绩排名出炉 医药基金继续领跑",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "[买入评级] 小分子靶向药物(医药生物行业)：医保谈判催化 竞争格局生变",
            "features": {
                "keywords": [
                    "小分子靶向药物",
                    "买入评级",
                    "医保谈判",
                    "竞争格局"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[买入评级] 小分子靶向药物(医药生物行业)：医保谈判催化 竞争格局生变",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "专访 | 恒瑞张连山：立项要理性，BD要“舍得交学费”",
            "features": {
                "keywords": [
                    "恒瑞",
                    "张连山",
                    "立项",
                    "BD",
                    "理性",
                    "学费"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "专访 | 恒瑞张连山：立项要理性，BD要“舍得交学费”",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        }
    ]
]